Author:
Wang Jingru,Yao Bo,Duan Liqing,Han Wenyi,Li Pu,Cai Zhihui,Liu Fei,Gou Shan,Xu Xiaoming,He Jingjun,Ling Qinjie,Hoffmann Peter R.,Xing Xiwen,HUANG ZHI
Reference52 articles.
1. Challenges and opportunities for antiviral monoclonal antibodies as COVID-19 therapy;C Cruz-Teran;Adv Drug Deliv Rev,2021
2. Antibody therapy of cancer;A M Scott;Nat Rev Cancer,2012
3. Targeting Negative and Positive Immune Checkpoints with Monoclonal Antibodies in Therapy of Cancer;K Marhelava;Cancers (Basel),2019
4. Therapeutic monoclonal antibodies;F C Breedveld;Lancet,2000
5. Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains;J B Case;Nat Commun,2022